Case Reports in Urology

Case Reports in Urology / 2015 / Article

Case Report | Open Access

Volume 2015 |Article ID 747261 | https://doi.org/10.1155/2015/747261

Daisaku Hirano, Mizuho Ohkawa, Ryo Hasegawa, Norimichi Okada, Naoki Ishizuka, Yoshiaki Kusumi, "Metastatic Tumor of the Spermatic Cord in Adults: A Case Report and Review", Case Reports in Urology, vol. 2015, Article ID 747261, 7 pages, 2015. https://doi.org/10.1155/2015/747261

Metastatic Tumor of the Spermatic Cord in Adults: A Case Report and Review

Academic Editor: Sandhya Srinivas
Received27 Sep 2015
Accepted18 Nov 2015
Published03 Dec 2015

Abstract

Metastatic spermatic cord (SC) tumor is extremely rare. Recently, we experienced a case of late-onset metastatic SC tumor from cecal cancer. This case is a 68-year-old man presenting with a painless right SC mass. He had undergone a right hemicolectomy for cecal cancer 6 years ago. Radical orchiectomy and adjuvant chemotherapy with S-1 were performed. No recurrence was found after one year of follow-up. We identified a total of 25 cases, including our case, on a literature search via PubMed from January 2000 to April 2015. The most frequent primary sites of the tumors metastasizing to the SC were the stomach (8 cases, 32%) and the colon (8 cases, 32%), next the liver (2 cases, 8%), and kidney (2 cases, 8%). The majority of the cases underwent radical orchiectomy for the metastatic tumors of the SC. Over half of the cases received adjuvant interventions based on the regimens for the primary tumors. Prognosis in the patients with metastatic tumor of the SC was unfavorable except for late-onset metastasis. In patients with a mass in the SC and a history of neoplasm, especially in gastrointestinal tract, the possibility of metastasis from the primary cancer should be considered.

1. Introduction

Tumors arising from the spermatic cord (SC) are rare and most of these tumors are benign such as lipoma. However, approximately 25% are potentially life-threating malignant neoplasms [1]. The most common malignant tumors comprise sarcomas such as liposarcoma, leiomyosarcoma, rhabdomyosarcoma, and malignant fibrous histiocytoma and occur as a result of a mutation of a pluripotent mesenchymal cell that transforms into a malignant population clones [2].

On the other hand, metastatic SC tumor is even more unusual [3]. Several investigators have indicated that the most frequent primary tumors metastasizing to the SC and peritesticular tissues have been neoplasms of the stomach and prostate [4]. The timings of the detection of SC metastasis in most previous reports have been synchronous or metachronous, and the majority of cases in the metachronous were found in less than several years after the treatment for primary tumors [4]. Recently, we experienced a patient with cecal cancer recurrence in the SC that occurred on late phase after radical hemicolectomy. Herein, we report this case and a review of the recent literatures.

2. Case Report

A 68-year-old man was referred to the Department of Urology from the Surgery at Higashimatsuyama Municipal Hospital with a right painless inguinal mass in April 2014. He had noticed it 6 months previously and observed an increase of its size. He had undergone right radical hemicolectomy for cecal cancer 6 years ago. Histological examination of the extirpated colon specimen showed moderately differentiated adenocarcinoma (Figure 1(a)) with depth of invasion of subserosa, lymphovascular invasion, and metastasis of the paracolic lymph nodes.

On physical examination, an approximately 4 × 3 cm palpable relatively fixed unpainful mass was observed in the right inguinal region. Abdominal computed tomography (CT) scan showed a heterogeneously slight-enhanced mass with noncapsulated irregular shape, 3.7 cm in diameter, suspicious of extending to the adjunct structures (Figure 2). Serum carcinoembryonic antigen (CEA) value was slightly elevated to 7.0 ng/mL (normal range < 5.0 ng/mL) but the levels of other tumor markers such as carbohydrate antigen 19-9 (CA19-9) and prostate-specific antigen (PSA) were normal. We did not deny that this tumor had been potentially malignant based on the clinical findings.

The patient underwent right radical orchiectomy. During the operation, the tumor was located in the SC and showed relatively invasive growth to the adjunct structures but did not invade the epididymis and testis. The resected specimen involved a 4.5 × 3.5 × 3 cm solid mass, with grayish-white tumor in the cut surface, and was located in the lower part of the SC (Figure 3).

A histological examination of the SC tumor showed moderately differentiated adenocarcinoma (Figure 1(b)). In an immunohistochemical examination, the tumor cells in the SC were stained for caudal-type homeobox- (CDX-) 2 (Figure 1(c)) and cytokeratin- (CK-) 20 (Figure 1(d)). Based on the histopathological and immunohistochemical findings, the SC tumor was compatible with a metastasis from the cecal cancer.

The postoperative course was uneventful. The patient received adjuvant chemotherapy with tegafur/gimeracil/oteracil (S-1) which is a combined oral chemotherapeutic agent and has been doing well without evidence of recurrence for one year following the surgery.

3. Discussion

The SC is an extremely rare site for distant metastasis from a malignant neoplasm. In an autopsy study there were only two metastatic sites (0.01%) of the SC among 13,500 autopsy cases, both of which were from a primary gastric cancer [3]. The most common primary origin of a SC metastasis was the stomach, followed by the prostate, ileum, kidney, and colon as previously reviewed by Algaba et al. [4]. That review is over thirty years old and to our knowledge, there have not been any reviews involving recent cases. We performed a literature search of the case reports on adult metastatic SC tumor via PubMed from January 2000 to April 2015. Table 1 shows identified cases [527] including our case since 2000. The mean age of incidence was 61 years (range: 36 to 85 years). The overall incidence was similar on both sites, but with respect to the colon cancers as the primary site the ascending colon and cecal cancers metastasized to the right SC while the descending colon and sigmoid cancers metastasized to the left SC. The most presenting symptoms were a mass in inguinal sites and scrotal swelling, both with and without pain except for one case that was incidentally found in an orchiectomy specimen due to the treatment of prostate cancer. The average metastatic tumor size of the SC in the identified 15 cases was 3.6 cm in a diameter (range: 1.6 to 6.5 cm). The most frequent primary origin of the tumor was the stomach (8 cases, 32%) and colon (8 cases, 32%), followed by liver (2 cases, 8%) and kidney (2 cases, 8%), and one case occurring in the small bowel, gastrointestinal tract, pancreas, lung, and prostate each. The average time between diagnosis of primary tumor and the presence of metastasis to the SC in the 15 metachronous cases (60%) was 42 months (range: 2 to 108 months), while seven cases (28%) were synchronously detected and three cases (12%) were found as an occult cancer. The metastatic SC tumors extending to the epididymitis were found in six (32%) of the identified 19 cases, of which two cases (11%) invaded the testis.


Case numberAuthor (year)Age SiteSymptomsTumor size (SC) in diameter, cmPrimary siteDuration of detection of SC metastasis from primary site diagnosis Histopathology (SC tumor)Involved structureTreatment (SC tumor)Prognosis after treatment

1Ota et al. [5] (2000) 51LeftPainless scrotal swelling2.5Stomach9 yearsPoorly differentiated adenocarcinomaEpididymis and parietal tunica vaginalisRadical orchiectomy + chemo (MTX, 5-FU)Died, 1 year

2Polychronidis et al. [6] (2002) 63LeftPainless scrotal swelling2Colon (sigmoid)OccultMucus-secreting adenocarcinomaIntactRadical orchiectomyND

3Bawa et al. [7] (2003)85LeftIncidentally found by castration NDProstate SynchronousAdenocarcinomaVas deferensRadical orchiectomy + hormone therapyND

4Salesi et al. [8] (2004) 62LeftMass in scrotumNDGastrointestinal tractOccultAdenocarcinomaEpididymitisOrchifunicolectomy + chemo (CDDP, Epirubicin, 5-FU)Died, 5 months

5Bandyopadhyay et al. [9] (2005) 67RightMass in groinNDPancreasSynchronousModerately differentiated adenocarcinomaNDRadical orchiectomy + distal pancreatectomy ND

6Kaya et al. [10] (2006) 62LeftPainful mass in inguinal site4.5Lung SynchronousNon-small cell adenocarcinomaIntactRadical orchiectomyDied, 2 weeks

7Shida et al. [11] (2006)75LeftMass in inguinal site5Colon (ascending)2 monthsPoorly differentiated adenocarcinomaIntactRadical orchiectomyDied, 6 months

8Miyake et al. [12] (2007) 60RightMass in inguinal site3Colon (ascending)1 year and 8 monthsModerately differentiated adenocarcinomaIntactRadical orchiectomy ND

9Paravastu et al. [13] (2007)62LeftPainless scrotal swellingND Colon (descending)SynchronousPoorly differentiated adenocarcinomaIntactRadical orchiectomy + chemo (irinotecan, fluorouracil, cetuximab)Alive, 18 months

10Galanis et al. [14] (2009)80RightPainful mass in inguinal siteNDColon (cecum, ascending, sigmoid) SynchronousAdenocarcinomaIntactRadical orchiectomy Died, early postoperative period

11Chang et al. [15] (2009) 38RightScrotal enlargement and chronic testicular painNDLiver7 monthsCholangiocarcinoma (Klatskin tumor)NDBiopsy of the spermatic cord tumor careful surveillanceAlive, 5 months

12Correa et al. [16] (2009)57LeftMass in inguinal site5Left kidneySynchronousRenal cell carcinoma clear cell typeNDRadical orchiectomy + radical nephrectomy + SunitinibAlive, 1 year

13Schaefer et al. [17] (2010) 64RightPainful mass in groin and scrotum2StomachSynchronousSignet ring cell carcinomaEpididymitis and testisRadical orchiectomy + chemo (paclitaxel, leucovorin, 5-FU: FLF regimen)Died, 1 year

14Ishibashi et al. [18] (2011)71RightMass in groin3.8Colon (cecum) 1 yearWell-differentiated adenocarcinomaIntactRadical orchiectomy + chemo (S-1) Alive, 15 months without recurrence

15Chiang et al. [19] (2011) 57RightPainful hard mass in inguinal site2Liver6 yearsHepatocellular carcinomaIntactRadical orchiectomy + adjuvant radiotherapy Alive, 6 months without recurrence

16Mohammadi et al. [20] (2011)57LeftPainless mass in high scrotal site6.5Left kidney3 yearsRenal cell carcinoma (clear cell type)NDTumor resection with preserved testisAlive, 3 months without recurrence

17Al-Ali et al. [21] (2012)77LeftInguinal and testicular painNDColon (descending)2.5 yearsAdenocarcinomaEpididymitis and capsule of the testisRadical orchiectomyND

18Lee et al. [22] (2012)57LeftMass in inguinal site4Stomach 3 yearsPoorly differentiated adenocarcinomaIntactRadical orchiectomy ND

19Watanabe et al. [23] (2013)52RightMass in inguinal and scrotal site2Stomach2 yearsPoorly differentiated adenocarcinomaNDRadical orchiectomy + chemo (CDDP)Died, 10 months

20Valizadeh et al. [24] (2013)36RightPainful mass in inguinal site1.6Small bowel OccultAdenocarcinomaNDRadical orchiectomy + small bowel tumor resection + chemo (capecitabine plus oxaliplatin regimen)Alive, 6 months without recurrence

21Kanazawa et al. [25] (2013) 66RightGroin pain 4.2Stomach1 yearModerately differentiated tubular adenocarcinomaNDTumor resection with preserved testis + chemo ND

22 Xu and Wang [26] (2013)50 BilMass in spermatic cordsNDStomach4 yearsSignet ring cell carcinomaEpididymitis and seminiferous ductRadical orchiectomyND

23Kim et al. [27] (2014), Case 149RightMass in scrotum with discomfort in spermatic cord4Stomach7 yearsMucinous adenocarcinoma with signet ring cell carcinomaEpididymitisRadical orchiectomy + chemo (folinic acid, fluorouracil, oxaliplatin; FOLFOX regimen)Alive, 26 months without recurrence

24Case 260LeftInguinal pain3.5Stomach6 yearsMucinous moderately differentiated adenocarcinomaIntactRadical orchiectomy + adjuvant radiationAlive, 20 months without recurrence

25Present study68RightPainless mass in inguinal site4.5Colon (cecum) 6 yearsModerately differentiated adenocarcinomaIntactRadical orchiectomy + chemo (S-1)Alive, 12 months without recurrence

S-1: tegafur/gimeracil/oteracil.
ND: Not document, SC: Spermatic cord.

The vast majority of cases as well as our case underwent radical orchiectomy for the metastatic tumors in the SC, while tumor resection alone with preservation of the testis was found in two cases (8%). Over half of the cases received adjuvant interventions such as chemotherapy, molecular therapy, or hormone therapy based on the regimens for the primary tumors.

The prognosis of a metastatic tumor in the SC has been typically unfavorable as previously reported [4]. In this review, the 2-year survival rate in the postmetastasis to the SC was 36% in a total of the 16 patients identified since 2000, including our case, using the Kaplan-Meier method with a median follow-up duration of 12 months (range: 0.47 to 26 months) (Figure 4). Although there have been a small number of cases and short follow-up duration, the prognosis in patients with a metastatic SC tumor seems to be unfavorable even in the recent cases. However, the patients with late-onset (6 years or more) metastasis to the SC are likely to be a favorable prognosis because four (80%) of the five patients had been alive without recurrence after radical orchiectomy with a mean follow-up duration of 16 months.

The mechanisms of metastasis to the SC and paratesticular tissues from primary malignant neoplasms have not been precisely elucidated. However, several possibilities have been proposed. The main routes have been postulated to be vascular and lymphatic routes. Other routes involving retrograde extension through the vessel, either along its lumen or by direct extension via the wall of the vessel, and transperitoneal seeding through the patent tunica vaginalis have been proposed [3, 4]. In our case hematogenous or lymphatic spread may be possible due to the positive lymphovascular invasion as well as the evidence of the paracolic lymph nodes metastasis in the primary neoplasm, and the late recurrence after the treatment of the primary site may be related to the activation of long-lasting tumor dormancy in distant organs including the SC.

In conclusion SC solid masses are usually not considered as SC metastasis from primary neoplasms such as gastrointestinal tract cancers previously treated with a curative intention. We did not initially consider this case to be a metastasis from cecal cancer. However, in patients with solid mass of the SC and a history of neoplasm, especially in the gastrointestinal tract, and even though the primary neoplasm has been treated with a curative intent long time earlier, the solid mass of the SC should be kept in mind in a possibility of metastasis from the primary tumor.

Written informed consent was obtained from the patient for publication of this case report and any accompanying images and extirpated specimens.

Conflict of Interests

The authors declare that there is no conflict of interests as to the publication of this paper.

Authors’ Contribution

Daisaku Hirano contributed to writing the paper including acquisition and analysis of data and surgery. Mizuho Ohkawa contributed to acquisition of data especially regarding prior reported cases. Ryo Hasegawa, Norimichi Okada, and Naoki Ishizuka contributed to surgery. Yoshiaki Kusumi contributed to carrying out the pathologic confirmation. All authors read and approved the final paper.

References

  1. D. Rodríguez and A. F. Olumi, “Management of spermatic cord tumors: a rare urologic malignancy,” Therapeutic Advances in Urology, vol. 4, no. 6, pp. 325–334, 2012. View at: Publisher Site | Google Scholar
  2. M. Arlen, H. Grabstald, and W. F. Whitmore Jr., “Malignant tumors of the spermatic cord,” Cancer, vol. 23, no. 3, pp. 525–532, 1969. View at: Publisher Site | Google Scholar
  3. N. Dutt, A. W. Bates, and S. I. Baithun, “Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children,” Histopathology, vol. 37, no. 4, pp. 323–331, 2000. View at: Publisher Site | Google Scholar
  4. F. Algaba, J. M. Santaularia, and H. Villavicencio, “Metastatic tumor of the epididymis and spermatic cord,” European Urology, vol. 9, no. 1, pp. 56–59, 1983. View at: Google Scholar
  5. T. Ota, M. Shinohara, M. Tanaka et al., “Spermatic cord metastases from gastric cancer with elevation of serum hCG-β: a case report,” Japanese Journal of Clinical Oncology, vol. 30, no. 5, pp. 239–240, 2000. View at: Publisher Site | Google Scholar
  6. A. Polychronidis, C. Tsolos, E. Sivridis, S. Botaitis, and C. Simopoulos, “Spermatic cord metastasis as an initial manifestation of sigmoid colon carcinoma: report of a case,” Surgery Today, vol. 32, no. 4, pp. 376–377, 2002. View at: Publisher Site | Google Scholar
  7. A. S. Bawa, R. Singh, V. K. Bansal, and R. S. Punia, “Spermatic cord metastasis from prostatic cancer,” Journal of Postgraduate Medicine, vol. 49, no. 1, pp. 97–98, 2003. View at: Publisher Site | Google Scholar
  8. N. Salesi, A. Fabi, B. Di Cocco et al., “Testis metastasis as an initial manifestation of an occult gastrointestinal cancer,” Anticancer Research, vol. 24, no. 2, pp. 1093–1096, 2004. View at: Google Scholar
  9. D. Bandyopadhyay, C. R. Kapadia, and P. E. Da Costa, “Pancreatic carcinoma: report of two cases presenting with unusual metastases,” Indian Journal of Gastroenterology, vol. 24, no. 2, pp. 75–76, 2005. View at: Google Scholar
  10. C. Kaya, H. Tanrikulu, G. Yilmaz, F. Aker, and M. I. Karaman, “Spermatic cord metastasis as an initial manifestation of non-small cell carcinoma of the lung,” International Journal of Urology, vol. 13, no. 6, pp. 846–848, 2006. View at: Publisher Site | Google Scholar
  11. Y. Shida, Y. Miyata, T. Igawa, H. Sakai, S. Koga, and H. Kanetake, “A case of metastatic tumor of spermatic cord from ascending colon carcinoma,” Hinyokika kiyo. Acta urologica Japonica, vol. 52, no. 9, pp. 733–735, 2006. View at: Google Scholar
  12. Y. Miyake, T. Kato, K. Katayama et al., “A case of ascending colon carcinoma metastasized to an inguinal hernia sac,” Gan To Kagaku Ryoho, vol. 34, no. 12, pp. 2016–2018, 2007. View at: Google Scholar
  13. S. C. V. Paravastu, M. Batra, and K. Ananthakrishnan, “Colonic carcinoma masquerading as scrotal swelling: a case report and review of literature,” TheScientificWorldJOURNAL, vol. 7, pp. 855–859, 2007. View at: Publisher Site | Google Scholar
  14. I. Galanis, G. Chatzimavroudis, A. Katsougiannopoulos, N. Galanis, J. Makris, and K. Atmatzidis, “Spermatic cord metastasis presenting as strangulated inguinal hernia—first manifestation of a multifocal colon adenocarcinoma: a case report,” Cases Journal, vol. 2, no. 1, article 61, 2009. View at: Publisher Site | Google Scholar
  15. Y.-H. Chang, C.-K. Chuang, K.-F. Ng, and S.-K. Liao, “Klatskin tumor with spermatic cord metastasis: a case report,” Chang Gung Medical Journal, vol. 32, no. 1, pp. 104–107, 2009. View at: Google Scholar
  16. J. J. Correa, M. Fishman, S.-T. Chuang, and P. E. Spiess, “Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasis,” Clinical Genitourinary Cancer, vol. 7, no. 3, pp. E101–E103, 2009. View at: Publisher Site | Google Scholar
  17. I.-M. Schaefer, U. Sauer, M. Liwocha, H. Schorn, H. Loertzer, and L. Füzesi, “Occult gastric signet ring cell carcinoma presenting as spermatic cord and testicular metastases: ‘Krukenberg tumor’ in a male patient,” Pathology Research and Practice, vol. 206, no. 7, pp. 519–521, 2010. View at: Publisher Site | Google Scholar
  18. K. Ishibashi, N. Chika, T. Miyazaki et al., “Spermatic cord metastasis from colon cancer: report of a case,” Surgery Today, vol. 41, no. 3, pp. 418–421, 2011. View at: Publisher Site | Google Scholar
  19. H. C. Chiang, P. H. Chen, and H. J. Shih, “Spermatic cord metastasis of primary hepatocellular carcinoma presenting as an inguinal mass: a case report,” ISRN Oncology, vol. 2011, Article ID 612753, 3 pages, 2011. View at: Publisher Site | Google Scholar
  20. A. Mohammadi, K. Malhdoomi, and M. Ghasemi-rad, “Metachronous metastasis to the spermatic cord from renal cell carcinoma presenting as a high scrotal mass: a case report,” Cancer Imaging, vol. 11, no. 1, pp. 163–165, 2011. View at: Publisher Site | Google Scholar
  21. B. M. Al-Ali, H. Augustin, H. Popper, and K. Pummer, “A case of descending colon carcinoma metastasized to left spermatic cord, testis, and epididymis,” Central European Journal of Urology, vol. 65, no. 2, pp. 94–95, 2012. View at: Publisher Site | Google Scholar
  22. K. Y. Lee, S. J. Park, S. K. Moon, and H. C. Kim, “Unilateral spermatic cord metastasis from gastric cancer: a case report,” Iranian Journal of Radiology, vol. 9, no. 4, pp. 217–219, 2012. View at: Publisher Site | Google Scholar
  23. R. Watanabe, K. Inada, Y. Yamashita, and A. Oka, “A case of metastatic tumor of the spermatic cord from gastric cancer,” Hinyokika Kiyo, vol. 59, no. 3, pp. 195–199, 2013. View at: Google Scholar
  24. N. Valizadeh, A. E. Oskuie, and A. Tehranchi, “Spermatic cord metastasis as early manifestation of small bowel adenocarcinoma,” Urology Annals, vol. 5, no. 1, pp. 53–55, 2013. View at: Publisher Site | Google Scholar
  25. Y. Kanazawa, S. Kato, I. Fujita et al., “Spermatic cord tumor metastatic from stomach cancer 1 year after curative gastrectomy,” Journal of Nippon Medical School, vol. 80, no. 4, pp. 318–323, 2013. View at: Publisher Site | Google Scholar
  26. F. Xu and Y. Wang, “Metastatic tumour of spermatic cords, epididymis and seminiferous duct from gastric carcinoma,” West Indian Medical Journal, vol. 62, no. 9, pp. 859–860, 2013. View at: Publisher Site | Google Scholar
  27. J. H. Kim, D. S. Kim, H. D. Cho, and M. S. Lee, “Late-onset metastatic adenocarcinoma of the spermatic cord from primary gastric cancer,” World Journal of Surgical Oncology, vol. 12, no. 1, article 128, 2014. View at: Publisher Site | Google Scholar

Copyright © 2015 Daisaku Hirano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views2241
Downloads370
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.